LanguaTalk

Want to create an interactive transcript for this episode?

View more episodes

Podcast: Foundation Fighting Blindness

Episode: ARVO 2025 Highlight: PYC Reports Encouraging Phase 1/2 Clinical Trial Results for its RNA Therapy Targeting RP (PRPF31 Mutations)

Description: The company is planning a Phase 2/3 clinical trial for therapy in late 2025.

Click any word to see translations, usage examples & similar words. Then learn them using saved words.

Text not synced with the audio? See here for why certain podcasts won't sync.

Key for transcripts:

saved words | learned words

Colours will update after you refresh the page.